Lerévérend C, Kotaich N, Cartier L, De Boni M, Lahire S, Fichel C, Thiebault C, Brabencova E, Maquin C, Barbosa E, Corsois L, Hotton J, Guendouzen S, Guilbert P, Lepagnol-Bestel AM, Cahen-Doidy L, Lehmann-Che J, Devy J, Bensussan A, Le Jan S, Pommier A, Merrouche Y, Le Naour R, Vignot S, Potteaux S

Int J Cancer. 2024 07 30;:

Elastin-derived peptides favor type 2 innate lymphoid cells in COPD.

Lahire S, Fichel C, Rubaszewski O, Lereverend C, Audonnet S, Visneux V, Perotin JM, Deslée G, Le Jan S, Potteaux S, Le Naour R, Pommier A

Am J Physiol Lung Cell Mol Physiol. 2024 05 7;:

Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications.

Scheffges C, Devy J, Giustiniani J, Francois S, Cartier L, Merrouche Y, Foussat A, Potteaux S, Bensussan A, Marie-Cardine A

Breast Cancer Res. 2024 02 15;26(1):28

[Mild dyslipidemia accelerates tumor growth through expansion of immunosuppressive and pro-angiogenic myeloid cells].

Tran T, Potteaux S

Med Sci (Paris). 2023 04;39(4):319-322

Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6C monocytes and differentiation to pro-angiogenic myeloid cells.

Tran T, Lavillegrand JR, Lereverend C, Esposito B, Cartier L, Montabord M, Tran-Rajau J, Diedisheim M, Gruel N, Ouguerram K, Paolini L, Lenoir O, Pinteaux E, Brabencova E, Tanchot C, Urquia P, Lehmann-Che J, Le Naour R, Merrouche Y, Stockmann C, Mallat Z, Tedgui A, Ait-Oufella H, Tartour E, Potteaux S

Nat Commun. 2022 09 14;13(1):5399

[Myocardial infarction exacerbates protumoral and immunosuppressive functions of inflammatory monocytes: A link between cardiovascular diseases and cancer].

Potteaux S, Tedgui A

Med Sci (Paris). 2021 09 7;37(8-9):706-708

Thymic stromal lymphopoietin is a key cytokine for the immunomodulation of atherogenesis with Freund's adjuvant.

Steinmetz M, Laurans L, Nordsiek S, Weiß L, van der Veken B, Ponnuswamy P, Esposito B, Vandestienne M, Giraud A, Göbbel C, Steffen E, Radecke T, Potteaux S, Nickenig G, Rassaf T, Tedgui A, Mallat Z

J Cell Mol Med. 2020 05;24(10):5731-5739

MicroRNA-21 Deficiency Alters the Survival of Ly-6C Monocytes in ApoE Mice and Reduces Early-Stage Atherosclerosis-Brief Report.

Chipont A, Esposito B, Challier I, Montabord M, Tedgui A, Mallat Z, Loyer X, Potteaux S

Arterioscler Thromb Vasc Biol. 2019 02;39(2):170-177

Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.

Williams JW, Martel C, Potteaux S, Esaulova E, Ingersoll MA, Elvington A, Saunders BT, Huang LH, Habenicht AJ, Zinselmeyer BH, Randolph GJ

Arterioscler Thromb Vasc Biol. 2018 08;38(8):1702-1710

Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet.

Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A, Mallat Z, Potteaux S, Taleb S

PLoS One. 2018 03 1;13(3):e0193737

Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production.

Giraud A, Zeboudj L, Vandestienne M, Joffre J, Esposito B, Potteaux S, Vilar J, Cabuzu D, Kluwe J, Seguier S, Tedgui A, Mallat Z, Lafont A, Ait-Oufella H

Cardiovasc Res. 2017 09 1;113(11):1364-1375

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Dr POTTEAUX Stéphane

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Projets

Identification et inhibition des isoformes secrétées de la Galectine-9 dans le cancer du sein triple négatif

Etude de la Galectine 9 dans le cancer du sein triple négatif en réponse à la radiothérapie : application possible pour une thérapie combinée

Etude de la Galectine 9 dans le cancer du sein triple négatif en réponse à la radiothérapie : application possible pour une thérapie combinée

Publications

Enhanced expression of galectin-9 in triple negative breast cancer cells following radiotherapy: Implications for targeted therapy.

Elastin-derived peptides favor type 2 innate lymphoid cells in COPD.

Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications.

[Mild dyslipidemia accelerates tumor growth through expansion of immunosuppressive and pro-angiogenic myeloid cells].

Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6C monocytes and differentiation to pro-angiogenic myeloid cells.

[Myocardial infarction exacerbates protumoral and immunosuppressive functions of inflammatory monocytes: A link between cardiovascular diseases and cancer].

Thymic stromal lymphopoietin is a key cytokine for the immunomodulation of atherogenesis with Freund's adjuvant.

MicroRNA-21 Deficiency Alters the Survival of Ly-6C Monocytes in ApoE Mice and Reduces Early-Stage Atherosclerosis-Brief Report.

Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.

Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet.

Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production.

The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice.

Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis.

Role of splenic monocytes in atherosclerosis.

Angiotensin II mobilizes spleen monocytes to promote the development of abdominal aortic aneurysm in Apoe-/- mice.

Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm.

Retrouvez aussi